AAAAAA

   
Results: 1-4 |
Results: 4

Authors: SACKTOR N KIEBURTZ K SCHIFITTO G MCDERMOTT M BOURGEOIS K PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L PLUMB S RUDOLPH A KAMP C EPSTEIN L MARDER K ALBERT S DOONEIEF G STERN Y TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T MAYEUX R SACKTOR N SELNES O HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR J OSULLIVAN J SHOULSON I OAKES D REICHMAN R
Citation: N. Sacktor et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEPRENYL AND THIOCTIC ACID IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED COGNITIVE IMPAIRMENT, Neurology, 50(3), 1998, pp. 645-651

Authors: KIEBURTZ K SCHIFITTO G MCDERMOTT M HEO M IRVINE C PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L EPSTEIN L MARDER K RAMACHANDRAN G ALBERT S DOONEIEF G STERN Y TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T MAYEUX R DALPAN G SELNES O SACKTOR N HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR JC SHOULSON I OAKES D REICHMAN R OSULLIVAN J
Citation: K. Kieburtz et al., SAFETY AND TOLERABILITY OF THE ANTIOXIDANT OPC-14117 IN HIV-ASSOCIATED COGNITIVE IMPAIRMENT, Neurology, 49(1), 1997, pp. 142-146

Authors: MARDER K ALBERT S DOONEIEF G STERN Y RAMACHANDRAN G TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T SCHOFIELD P MAYEUX R PAN GD SELNES O SACKTOR N HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR J KIEBURTZ K SCHIFITTO G MCDERMOTT M PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L EPSTEIN L
Citation: K. Marder et al., CLINICAL CONFIRMATION OF THE AMERICAN-ACADEMY-OF-NEUROLOGY ALGORITHM FOR HIV-ASSOCIATED COGNITIVE MOTOR DISORDER/, Neurology, 47(5), 1996, pp. 1247-1253

Authors: KIEBURTZ K MCDERMOTT M SHOULSON I OAKES D FAHN S LANG A PENNEY JB RODNITZKY R SHULTS C TANNER C TETRUD J GORDON M LEWITT P BENNETT J KOLLER W FRIEDMAN JH KURLAN R OBRIEN C MARK MH WEINER WJ SANCHEZRAMOS J PAULSON G COMELLA C JANKOVIC J OLANOW W SHANNON K LEWIS P WINFIELD L CIECIERSKI K MISTURA K LANDOW E DIETRICH S GEBHARDT AM BARTER R KENNEDY D CULLEN KA GARDINER IF BERGEN M PATTERSON V FABRIELE M SHELDON C CORNELIUS L DUDTE K THELEN JA DUNNE C GAUGER L MALAPIRA T COURVILLE K TROTTER H PELUSIO RM RUDOLPH A CASACELI C MILLER C BOETTRICH C CONNORTON J BYRNE L ORME C BORDWELL K MCMANUS J SOTACK J RANDOLPH H KAVANAUGH B BAKER D RUMFOLA L NOBEL R EBERLY S PLUMB S WATTS A GERWITZ K DARCY S EVANS P FREDERICK D DELLAPENA L SINGLETARY V TARIOT P BELL E GRIGGS RC HALL WJ HERNDON R MARSDEN CD CHASE TN COHEN G FLEISS J JACOBS L MOSS AJ MELAMED E DORFLINGER E YOO K SHIMOUN G MORAWSKY L
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347
Risultati: 1-4 |